|
Delayed
Australian S.E.
20:50:13 2026-09-08 EDT
|
5-day change | 1st Jan Change | ||
| 1.140 AUD | +0.88% |
|
+3.17% | +171.43% |
| 09-01 | BLS Pharmaceuticals Limited, 2026 Earnings Call, Sep 02, 2026 | |
| 08-31 | BLS Pharmaceuticals Limited Provides Earnings Guidance for the Fiscal Year 2027 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 183M | - | - | - | - | - |
| 48.41B | |||||
| 45.01B | - | - | - | - | - |
| 44.07B | |||||
| 40.73B | |||||
| 33.21B |
Select your edition
All financial news and data tailored to specific country editions
